Weighing the Risks and Benefits of Antidepressants in Idiopathic Intracranial Hypertension

J Neuroophthalmol. 2018 Mar;38(1):128-129. doi: 10.1097/WNO.0000000000000595.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antidepressive Agents
  • Humans
  • Obesity
  • Pseudotumor Cerebri*
  • Risk Assessment
  • Weight Loss

Substances

  • Antidepressive Agents